PhD defence by Kristine Langthaler
Development of novel experimental methods to predict brain drug exposure
- With a focus to validate the Göttingen minipig as a preclinical species for application in CNS drug discovery
Assessment committee
(Chairperson) Professor Hanne Mørck Nielsen, University of Copenhagen
Dr Stephen Buckley, Novo Nordisk A/S, Denmark
Dr Markus Fridén, AstraZeneca, Sweden
Supervisors
Professor Birger Brodin Larsen, University of Copenhagen
Research Fellow Christopher Jones, H. Lundbeck A/S, Denmark
Director Christoffer Bundgaard, H. Lundbeck A/S, Denmark
Department
Department of Pharmacy
Graduate programme
Pharmaceutical Sciences
Place of study
The experimental work took place at the Department of Pharmacy, University of Copenhagen, at the Department of Translational DMPK, H. Lundbeck A/S, Denmark, and at the Department of Translational PKPD, Department of Pharmacy, Uppsala University, Sweden.
Place
Auditorium 4, building 14
University of Copenhagen
PharmaSchool
Universitetsparken 2
2100 Copenhagen
Ask for a copy of the thesis
kristine_langthaler@hotmail.com